| abstract |
CpG reduced nucleic acid variants encoding the FVIII protein and methods of use thereof are described. In certain embodiments, the CpG reduced nucleic acid variant encoding FVIII is more efficiently expressed by the cell, secreted at an increased level by the cell relative to the wild-type Factor VIII protein, or increased expression and / / RTI > and / or activity or packaged more efficiently into viral vectors. |